Trexquant Investment LP Bicycle Therapeutics PLC Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$16.75 - $26.1 $1.74 Million - $2.71 Million	-103,771 Reduced 52.86%	92,552 $2.3 Million
Q4 2023 Feb 09, 2024	BUY	$13.29 - $22.2 $1.67 Million - $2.79 Million	125,604 Added 177.61%	196,323 $3.55 Million
Q3 2023 Nov 13, 2023	BUY	$19.9 - $26.25 $1.41 Million - $1.86 Million	70,719 New	70,719 $1.42 Million
Q2 2022 Aug 11, 2022	BUY	$12.95 - $46.99 $141,142 - $512,144	10,899 New	10,899 $183,000
Q1 2022 May 13, 2022	SELL	$40.12 - $59.5 $175,324 - $260,015	-4,370 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $182,229 - $267,181	4,370 New	4,370 $266,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $419M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.